Kestra Advisory Services’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,543
Closed -$685K 2272
2023
Q3
$685K Buy
1,543
+13
+0.8% +$5.87K 0.01% 1196
2023
Q2
$663K Sell
1,530
-13
-0.8% -$7.31K 0.01% 1180
2023
Q1
$916K Sell
1,543
-315
-17% -$176K 0.01% 985
2022
Q4
$750K Buy
1,858
+34
+2% +$15.9K 0.01% 1189
2022
Q3
$1.07M Buy
+1,824
New +$1.09M 0.01% 945

Other funds holding AGL

Kestra Advisory Services's AGL Position: Q4 2023 in Review

Kestra Advisory Services sold out of Agilon Health (AGL) in Q4 2023, closing a stake of 1,543 shares — an estimated $685K sold.

Kestra Advisory Services first reported a position in AGL in Q3 2022 and held it in 5 quarters. The position peaked at $1.07M in Q3 2022. 193 funds tracked by Wall St. Rank hold AGL as of Q4 2023.

  • Kestra Advisory Services reported no remaining Agilon Health position as of Q4 2023 after selling out during the quarter.
  • Kestra Advisory Services sold 1,543 Agilon Health shares in Q4 2023, an estimated $685K.
  • Kestra Advisory Services first reported a position in Agilon Health in Q3 2022 and held it in 5 quarters.
  • Kestra Advisory Services's Agilon Health position peaked at $1.07M in Q3 2022.
  • 193 funds tracked by Wall St. Rank held Agilon Health as of Q4 2023.

Based on Kestra Advisory Services's 13F filing for Q4 2023, filed 14 Feb 2024.